Upside â $MEDS +36% (preliminary September pharmacy revenue exceeded $1M, rising more than 66% from July) â $ACN +17% (Q4 beat with $22.2B of bookings and stronger operating margins) â $ABAT +13% (receives federal approval to export up to $100M of recycled black-mass material) â $QSI +13% (no clear fresh catalyst identified; unusually large move âŚ
Read in context âşMcCormick & Company Stock (MKC)
Track McCormick & Company stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
MKC
McCormick & Company
consumerdefensive
At close
$44.81
âź -1.13 (-2.46%)
Oct 9, 4:00 PM ET
After-hours
$44.84
Ⲡ+0.03 (+0.07%)
Oct 9, 7:58 PM ET
Market Cap
$12.39B
P/E Ratio
8.1x
1Y Return
-30.03%
EPS (TTM)
$5.53
Read the latest TheStreet Pro articles mentioning McCormick & Company, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
28 articlesDaily Diary Mentions
1 mentionUpside, Downside Movers in the Morning




